Document is current

Any future updates will be listed below

Cost-effectiveness analysis of olanzapine in four-drug antiemetic therapy in Japanese patients treated with highly emetogenic cisplatin-containing chemotherapy

Crossref DOI link: https://doi.org/10.1186/s40780-022-00246-x

Published Online: 2022-06-01

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark